David C Gemperline
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Systemic Lupus Erythematosus Research, Glycosylation and Glycoproteins Research, Data Analysis with R, RNA modifications and cancer
Most-Cited Works
- → mwaskom/seaborn: v0.8.1 (September 2017)(2017)415 cited
- → Autophagic Degradation of the 26S Proteasome Is Mediated by the Dual ATG8/Ubiquitin Receptor RPN10 in Arabidopsis(2015)410 cited
- → mwaskom/seaborn: v0.9.0 (July 2018)(2018)174 cited
- → mwaskom/seaborn: v0.10.0 (January 2020)(2020)54 cited
- → Struct-NB: predicting protein-RNA binding sites using structural features(2010)42 cited
- → Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients(2018)36 cited
- → mwaskom/seaborn: v0.11.0 (Sepetmber 2020)(2020)36 cited
- → mwaskom/seaborn: v0.11.1 (December 2020)(2020)36 cited
- → Proteomic analysis of affinity-purified 26S proteasomes identifies a suite of assembly chaperones in Arabidopsis(2019)30 cited
- → Endogenously produced itaconate negatively regulates innate-driven cytokine production and drives global ubiquitination in human macrophages(2024)29 cited